Literature DB >> 23134879

Immunogenicity of monococcum wheat in celiac patients.

Carmen Gianfrani1, Mariatonia Maglio, Vera Rotondi Aufiero, Alessandra Camarca, Immacolata Vocca, Gaetano Iaquinto, Nicola Giardullo, Norberto Pogna, Riccardo Troncone, Salvatore Auricchio, Giuseppe Mazzarella.   

Abstract

BACKGROUND: Research is intense to find wheat of low or null toxicity for patients with celiac disease (CD). Among candidates, there are diploid wheat species.
OBJECTIVE: We compared the immunological properties of 2 lines of diploid monococcum wheat (Triticum monococcum ssp. monococcum), Monlis and ID331, with those of common wheat (Triticum aestivum).
DESIGN: Interferon-γ production and the proliferation of intestinal gliadin-specific T cell lines and clones were measured as evidence of T cell activation by peptic and tryptic (PT) digests of gliadins from 2 monococcum lines. Furthermore, organ cultures of jejunal biopsies from 28 CD patients were set up to assess the effects of PT gliadin on innate and adaptive immune response by using immunohistochemistry.
RESULTS: Monlis and ID331 induced interferon-γ production and proliferation in celiac mucosal T cells. In organ cultures, Monlis PT digest induced a significant increase of IL-15 epithelial expression and crypt enterocyte proliferation, whereas ID331 had no effect. Both monococcum lines caused intraepithelial T cell infiltration and lamina propria T cell activation.
CONCLUSIONS: Our data show that the monococcum lines Monlis and ID331 activate the CD T cell response and suggest that these lines are toxic for celiac patients. However, ID331 is likely to be less effective in inducing CD because of its inability to activate the innate immune pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23134879     DOI: 10.3945/ajcn.112.040485

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  13 in total

1.  Testing the safety of alternative wheat species and cultivars for consumption by celiac patients.

Authors:  Eric V Marietta; Joseph A Murray
Journal:  Am J Clin Nutr       Date:  2012-11-07       Impact factor: 7.045

Review 2.  Latest in vitro and in vivo models of celiac disease.

Authors:  Samantha Stoven; Joseph A Murray; Eric V Marietta
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

3.  Wheat-induced food allergy in childhood: ancient grains seem no way out.

Authors:  Steven Sievers; Alexander Rohrbach; Kirsten Beyer
Journal:  Eur J Nutr       Date:  2019-10-25       Impact factor: 5.614

Review 4.  Cereal-based gluten-free food: how to reconcile nutritional and technological properties of wheat proteins with safety for celiac disease patients.

Authors:  Carmela Lamacchia; Alessandra Camarca; Stefania Picascia; Aldo Di Luccia; Carmen Gianfrani
Journal:  Nutrients       Date:  2014-01-29       Impact factor: 5.717

Review 5.  The gluten-free diet: testing alternative cereals tolerated by celiac patients.

Authors:  Isabel Comino; María de Lourdes Moreno; Ana Real; Alfonso Rodríguez-Herrera; Francisco Barro; Carolina Sousa
Journal:  Nutrients       Date:  2013-10-23       Impact factor: 5.717

Review 6.  Do ancient types of wheat have health benefits compared with modern bread wheat?

Authors:  Peter R Shewry
Journal:  J Cereal Sci       Date:  2018-01       Impact factor: 3.616

7.  The Diverse Potential of Gluten from Different Durum Wheat Varieties in Triggering Celiac Disease: A Multilevel In Vitro, Ex Vivo and In Vivo Approach.

Authors:  Federica Gaiani; Sara Graziano; Fatma Boukid; Barbara Prandi; Lorena Bottarelli; Amelia Barilli; Arnaldo Dossena; Nelson Marmiroli; Mariolina Gullì; Gian Luigi de'Angelis; Stefano Sforza
Journal:  Nutrients       Date:  2020-11-20       Impact factor: 5.717

8.  Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease.

Authors:  Barbara Zanini; Beatrice Petroboni; Tarcisio Not; Nicola Di Toro; Vincenzo Villanacci; Francesco Lanzarotto; Norberto Pogna; Chiara Ricci; Alberto Lanzini
Journal:  BMC Gastroenterol       Date:  2013-05-24       Impact factor: 3.067

Review 9.  Risk factors for celiac disease.

Authors:  Marco Sarno; Valentina Discepolo; Riccardo Troncone; Renata Auricchio
Journal:  Ital J Pediatr       Date:  2015-08-14       Impact factor: 2.638

10.  Immunogenic Potential of Beer Types Brewed With Hordeum and Triticum spp. Malt Disclosed by Proteomics.

Authors:  Valentina Spada; Luigia Di Stasio; Stefania Picascia; Bernardo Messina; Carmen Gianfrani; Gianfranco Mamone; Gianluca Picariello
Journal:  Front Nutr       Date:  2020-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.